How much does gene therapy cost?

Written by Lila Levinson, PhD |

A

How much does gene therapy cost?

Category: SMA Gene Therapy

Zolgensma and Itvisma, the two approved gene therapies for spinal muscular atrophy (SMA), have a U.S. list price of $2.5 million and $2.59 million, respectively. Novartis, the company that sells both therapies, offers a patient support program that provides one-on-one assistance to families of patients prescribed Zolgensma and Itvisma.

Lila Levinson, PhD avatar

About the Author

Lila Levinson, PhD Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the University of Washington Computational Neuroscience Center. She enjoys exploring the Pacific Northwest and spending time with her cat, Fibonacci.
Doctor finder promo


Recommended reading